Veterinary Compounding Pharmacies Market, 2012 to 2023
Global Veterinary Compounding Pharmacies Market
Veterinary compounding is a procedure in which drugs are prepared instantaneously described on the label of a drug in order to make it more accessible for the treatment of animals. Various forms of manipulation of drugs in a veterinary compounding practice include the change of drug’s original dosage form, the addition of different flavours to the drug in order to make it as more palatable to animals, changing the concentration and dilution of a drug, mixing of multiple drugs into the single-dose application.
Rise in the adoption of companion animals, inclination towards customized or tailored dosage of drugs, in order to enhance compliance of animals with an alternate route of administration and flavours of the drugs are expected to boost the demand for animal compounding pharmacies. Increased focus of dispensing smooth, creamy and non-gritty drugs to the animals, rise in the availability of different flavours in the dosages of the drugs which are given by compounding pharmacists, growing awareness of generic medications in veterinary healthcare among the pet owners are the few factors which are expected to fuel the growth of veterinary compounding pharmacies market.
Veterinary Compounding Pharmacies Market is segmented on basis of type of livestock, product type, and Geographical regions.
Based on the type of animal, the global veterinary compounding pharmacies market is segmented:
Swine
Poultry
Ovine
Bovine
Equine
Canine
Aquaculture
Based on the type of dosage form, the global veterinary compounding pharmacies market is segmented:
Flavoured Liquids
Tablet Triturates
Transdermal
Capsules
Flavoured pastes
Contemporarily there are many drugs which are approved to treat animals. Unmet therapeutic needs to treat rare diseases in animals are expected to create demand for compounded drugs. As an exemplary, many chemotherapeutic drugs which are approved by FDA are used for the cancer treatment of cats and dogs. The safest and effective therapy which is used for the treat cats with chronic constipation is banned from US stores, few such factors are reportedly increasing the trend and adoption of the veterinary compounding pharmacies globally.
Veterinary compounding pharmacies market is segmented into North America, Asia-Pacific, Europe, and the Middle East & Africa, Latin America. Veterinary compounding pharmacies market is dominated by North America followed by Europe due to increasing practitioners in veterinary and well established veterinary healthcare. Asia Pacific market is expected to create new opportunities for the market players due to increase in the adoption of animals, growing health concerns about the pets in China and India.
Some of the players in veterinary compounding pharmacies market are Triangle Compounding Pharmacy Inc. (U.S), Diamondback Drugs LLC (U.S), Lorraine’s Pharmacy (Ontario), Medisca Inc. (Canada), Slade Dispensary Services (Australia), Wedgewood Pharmacy (U.S), Essential Pharmacy Compounding Vet (Kohll’s Pharmacy & Homecare) (U.S).
In Jan 2016, Ceva Santé Animale and Zoion Pharma Inc. came into a collaboration for the development of epithelial sodium channel (ENaC) inhibitor for the treatment of veterinary ocular surface diseases.
Veterinary compounding is a procedure in which drugs are prepared instantaneously described on the label of a drug in order to make it more accessible for the treatment of animals. Various forms of manipulation of drugs in a veterinary compounding practice include the change of drug’s original dosage form, the addition of different flavours to the drug in order to make it as more palatable to animals, changing the concentration and dilution of a drug, mixing of multiple drugs into the single-dose application.
Rise in the adoption of companion animals, inclination towards customized or tailored dosage of drugs, in order to enhance compliance of animals with an alternate route of administration and flavours of the drugs are expected to boost the demand for animal compounding pharmacies. Increased focus of dispensing smooth, creamy and non-gritty drugs to the animals, rise in the availability of different flavours in the dosages of the drugs which are given by compounding pharmacists, growing awareness of generic medications in veterinary healthcare among the pet owners are the few factors which are expected to fuel the growth of veterinary compounding pharmacies market.
Veterinary Compounding Pharmacies Market is segmented on basis of type of livestock, product type, and Geographical regions.
Based on the type of animal, the global veterinary compounding pharmacies market is segmented:
Swine
Poultry
Ovine
Bovine
Equine
Canine
Aquaculture
Based on the type of dosage form, the global veterinary compounding pharmacies market is segmented:
Flavoured Liquids
Tablet Triturates
Transdermal
Capsules
Flavoured pastes
Contemporarily there are many drugs which are approved to treat animals. Unmet therapeutic needs to treat rare diseases in animals are expected to create demand for compounded drugs. As an exemplary, many chemotherapeutic drugs which are approved by FDA are used for the cancer treatment of cats and dogs. The safest and effective therapy which is used for the treat cats with chronic constipation is banned from US stores, few such factors are reportedly increasing the trend and adoption of the veterinary compounding pharmacies globally.
Veterinary compounding pharmacies market is segmented into North America, Asia-Pacific, Europe, and the Middle East & Africa, Latin America. Veterinary compounding pharmacies market is dominated by North America followed by Europe due to increasing practitioners in veterinary and well established veterinary healthcare. Asia Pacific market is expected to create new opportunities for the market players due to increase in the adoption of animals, growing health concerns about the pets in China and India.
Some of the players in veterinary compounding pharmacies market are Triangle Compounding Pharmacy Inc. (U.S), Diamondback Drugs LLC (U.S), Lorraine’s Pharmacy (Ontario), Medisca Inc. (Canada), Slade Dispensary Services (Australia), Wedgewood Pharmacy (U.S), Essential Pharmacy Compounding Vet (Kohll’s Pharmacy & Homecare) (U.S).
In Jan 2016, Ceva Santé Animale and Zoion Pharma Inc. came into a collaboration for the development of epithelial sodium channel (ENaC) inhibitor for the treatment of veterinary ocular surface diseases.
1. EXECUTIVE SUMMARY
2. GLOBAL VETERINARY COMPOUNDING PHARMACIES MARKET INTRODUCTION
2.1. Global Veterinary Compounding Pharmacies Market – Taxonomy
2.2. Global Veterinary Compounding Pharmacies Market –Definitions
2.2.1. Animal Type
2.2.2. Formulation
3. GLOBAL VETERINARY COMPOUNDING PHARMACIES MARKET DYNAMICS
3.1. Drivers
3.2. Restraints
3.3. Opportunities/Unmet Needs of the Market
3.4. Trends
3.5. Global Veterinary Compounding Pharmacies Market Dynamic Factors - Impact Analysis
3.6. Global Veterinary Compounding Pharmacies Market – Regulations
3.6.1. U.S.
3.6.2. Europe
3.7. Global Veterinary Compounding Pharmacies Market –Trends
4. GLOBAL VETERINARY COMPOUNDING PHARMACIES MARKET ANALYSIS, 2012 – 2016 AND FORECAST, 2017 – 2023
4.1. Market Analysis, 2012 - 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
4.2. Year-over-Year (Y-o-Y) Growth Analysis (%)
4.3. Market Opportunity Analysis
5. GLOBAL VETERINARY COMPOUNDING PHARMACIES MARKET FORECAST, BY TYPE OF ANIMAL, 2012 - 2016 AND FORECAST, 2017 – 2023
5.1. Swine
5.1.1. Market Analysis, 2012 - 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
5.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.1.3. Market Opportunity Analysis
5.2. Bovine
5.2.1. Market Analysis, 2012 - 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
5.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.2.3. Market Opportunity Analysis
5.3. Equine
5.3.1. Market Analysis, 2012 - 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
5.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.3.3. Market Opportunity Analysis
5.4. Canine
5.4.1. Market Analysis, 2012 - 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
5.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.4.3. Market Opportunity Analysis
6. GLOBAL VETERINARY COMPOUNDING PHARMACIES MARKET FORECAST, BY FORMULATION, 2012 - 2016 AND FORECAST, 2017 – 2023
6.1. Flavoured Liquids
6.1.1. Market Analysis, 2012 - 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
6.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.1.3. Market Opportunity Analysis
6.2. Tablet Triturates
6.2.1. Market Analysis, 2012 - 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
6.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.2.3. Market Opportunity Analysis
6.3. Transdermal
6.3.1. Market Analysis, 2012 - 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
6.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.3.3. Market Opportunity Analysis
6.4. Capsules
6.4.1. Market Analysis, 2012 - 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
6.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.4.3. Market Opportunity Analysis
6.5. Flavoured pastes
6.5.1. Market Analysis, 2012 - 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
6.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.5.3. Market Opportunity Analysis
7. GLOBAL VETERINARY COMPOUNDING PHARMACIES MARKET FORECAST, BY REGION, 2012 - 2016 AND FORECAST, 2017 – 2023 (REVENUE, USD MN)
7.1. North America
7.1.1. Market Analysis, 2012 - 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
7.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.1.3. Market Opportunity Analysis
7.2. Europe
7.2.1. Market Analysis, 2012 - 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
7.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.2.3. Market Opportunity Analysis
7.3. Asia-Pacific
7.3.1. Market Analysis, 2012 - 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
7.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.3.3. Market Opportunity Analysis
7.4. Latin America
7.4.1. Market Analysis, 2012 - 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
7.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.4.3. Market Opportunity Analysis
7.5. Middle East and Africa
7.5.1. Market Analysis, 2012 - 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
7.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.5.3. Market Opportunity Analysis
7.6. Global Veterinary Compounding Pharmacies Market - Opportunity Analysis Index, By Animal Type, By Formulation and Region, 2017 – 2023
8. NORTH AMERICA VETERINARY COMPOUNDING PHARMACIES MARKET ANALYSIS, 2012 - 2016 AND FORECAST, 2017 – 2023 (REVENUE, USD MN)
8.1. Animal Type Analysis, 2012 - 2016 and Forecast 2017 – 2023 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
8.1.1. Swine
8.1.2. Bovine
8.1.3. Equine
8.1.4. Canine
8.2. Formulation Analysis, 2012- 2016 and Forecast 2017 – 2023 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
8.2.1. Veterinary Clinics
8.2.2. Veterinary pharmacies
8.2.3. Online pharmacies
8.2.4. Others
8.3. Country Analysis 2016 and Forecast 2017 – 2023 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
8.3.1. U.S.
8.3.2. Canada
8.4. North America Veterinary Compounding Pharmacies Market - Opportunity Analysis Index, By Animal Type, By Formulation and Country, 2017 – 2023
8.5. North America Veterinary Compounding Pharmacies Market Dynamics – Trends
9. EUROPE VETERINARY COMPOUNDING PHARMACIES MARKET ANALYSIS, 2012 - 2016 AND FORECAST, 2017 – 2023 (REVENUE, USD MN)
9.1. Animal Type Analysis, 2012 - 2016 and Forecast 2017 – 2023 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
9.1.1. Swine
9.1.2. Bovine
9.1.3. Equine
9.1.4. Canine
9.2. Formulation Analysis, 2012- 2016 and Forecast 2017 – 2023 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
9.2.1. Veterinary Clinics
9.2.2. Veterinary pharmacies
9.2.3. Online pharmacies
9.2.4. Others
9.3. Country Analysis 2012 - 2016 and Forecast 2017 – 2023 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
9.3.1. Germany
9.3.2. UK
9.3.3. France
9.3.4. Spain
9.3.5. Italy
9.3.6. Russia
9.3.7. Poland
9.3.8. Rest of Europe
9.4. Europe Veterinary Compounding Pharmacies Market - Opportunity Analysis Index, By Animal Type, By Formulation and Country, 2017 – 2023
9.5. Europe Veterinary Compounding Pharmacies Market Dynamics – Trends
10. ASIA-PACIFIC VETERINARY COMPOUNDING PHARMACIES MARKET ANALYSIS, 2012 - 2016 AND FORECAST, 2017 – 2023 (REVENUE, USD MN)
10.1. Animal Type Analysis, 2012 - 2016 and Forecast 2017 – 2023 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
10.1.1. Swine
10.1.2. Bovine
10.1.3. Equine
10.1.4. Canine
10.2. Formulation Analysis, 2012- 2016 and Forecast 2017 – 2023 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
10.2.1. Veterinary Clinics
10.2.2. Veterinary pharmacies
10.2.3. Online pharmacies
10.2.4. Others
10.3. Country Analysis 2012 - 2016 and Forecast 2017 – 2023 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
10.3.1. Japan
10.3.2. China
10.3.3. India
10.3.4. ASEAN
10.3.5. Australia & New Zealand
10.3.6. Rest of Asia-Pacific
10.4. Asia-Pacific Veterinary Compounding Pharmacies Market - Opportunity Analysis Index, By Animal Type, By Formulation and Country, 2017 – 2023
10.5. Asia-Pacific Veterinary Compounding Pharmacies Market Dynamics – Trends
11. LATIN AMERICA VETERINARY COMPOUNDING PHARMACIES MARKET ANALYSIS, 2012 - 2012 - 2012 - 2016 AND FORECAST, 2017 – 2023 (REVENUE, USD MN)
11.1. Animal Type Analysis, 2012 - 2016 and Forecast 2017 – 2023 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
11.1.1. Swine
11.1.2. Bovine
11.1.3. Equine
11.1.4. Canine
11.2. Formulation Analysis, 2012- 2016 and Forecast 2017 – 2023 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
11.2.1. Veterinary Clinics
11.2.2. Veterinary pharmacies
11.2.3. Online pharmacies
11.2.4. Others
11.3. Country Analysis 2012 - 2016 and Forecast 2017 – 2023 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
11.3.1. Brazil
11.3.2. Mexico
11.3.3. Argentina
11.3.4. Venezuela
11.3.5. Rest of Latin America
11.4. Latin America Veterinary Compounding Pharmacies Market - Opportunity Analysis Index, By Animal Type, By Formulation and Country, 2017 – 2023
11.5. Latin America Veterinary Compounding Pharmacies Market Dynamics – Trends
12. MIDDLE EAST AND AFRICA VETERINARY COMPOUNDING PHARMACIES MARKET ANALYSIS, 2012 - 2016 AND FORECAST, 2017 – 2023 (REVENUE, USD MN)
12.1. Animal Type Analysis, 2012 - 2016 and Forecast 2017 – 2023 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
12.1.1. Swine
12.1.2. Bovine
12.1.3. Equine
12.1.4. Canine
12.2. Formulation Analysis, 2012- 2016 and Forecast 2017 – 2023 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
12.2.1. Veterinary Clinics
12.2.2. Veterinary pharmacies
12.2.3. Online pharmacies
12.2.4. Others
12.3. Country Analysis 2012 - 2016 and Forecast 2017 – 2023 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
12.3.1. Gulf Cooperation Council (GCC) Countries
12.3.2. Israel
12.3.3. South Africa
12.3.4. Rest of MEA
12.4. MEA Veterinary Compounding Pharmacies Market - Opportunity Analysis Index, By Animal Type, By Formulation and Country, 2017 – 2023
12.5. MEA Veterinary Compounding Pharmacies Market Dynamics – Trends
13. COMPETITION LANDSCAPE
13.1. Strategic Dashboard of Top Market Players
13.2. Company Profiles (Introduction, Financial Analysis, Product & Service Offerings, Key Developments, Strategies, and SWOT Analysis)
13.2.1. Triangle Compounding Pharmacy Inc. (U.S)
13.2.2. Diamondback Drugs LLC (U.S)
13.2.3. Lorraine’s Pharmacy (Ontario)
13.2.4. Medisca Inc. (Canada)
13.2.5. Slade Dispensary Services (Australia)
13.2.6. Wedgewood Pharmacy (U.S)
13.2.7. Essential Pharmacy Compounding Vet (Kohll’s Pharmacy & Homecare) (U.S)
14. RESEARCH METHODOLOGY
15. KEY ASSUMPTIONS AND ACRONYMS
2. GLOBAL VETERINARY COMPOUNDING PHARMACIES MARKET INTRODUCTION
2.1. Global Veterinary Compounding Pharmacies Market – Taxonomy
2.2. Global Veterinary Compounding Pharmacies Market –Definitions
2.2.1. Animal Type
2.2.2. Formulation
3. GLOBAL VETERINARY COMPOUNDING PHARMACIES MARKET DYNAMICS
3.1. Drivers
3.2. Restraints
3.3. Opportunities/Unmet Needs of the Market
3.4. Trends
3.5. Global Veterinary Compounding Pharmacies Market Dynamic Factors - Impact Analysis
3.6. Global Veterinary Compounding Pharmacies Market – Regulations
3.6.1. U.S.
3.6.2. Europe
3.7. Global Veterinary Compounding Pharmacies Market –Trends
4. GLOBAL VETERINARY COMPOUNDING PHARMACIES MARKET ANALYSIS, 2012 – 2016 AND FORECAST, 2017 – 2023
4.1. Market Analysis, 2012 - 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
4.2. Year-over-Year (Y-o-Y) Growth Analysis (%)
4.3. Market Opportunity Analysis
5. GLOBAL VETERINARY COMPOUNDING PHARMACIES MARKET FORECAST, BY TYPE OF ANIMAL, 2012 - 2016 AND FORECAST, 2017 – 2023
5.1. Swine
5.1.1. Market Analysis, 2012 - 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
5.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.1.3. Market Opportunity Analysis
5.2. Bovine
5.2.1. Market Analysis, 2012 - 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
5.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.2.3. Market Opportunity Analysis
5.3. Equine
5.3.1. Market Analysis, 2012 - 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
5.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.3.3. Market Opportunity Analysis
5.4. Canine
5.4.1. Market Analysis, 2012 - 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
5.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.4.3. Market Opportunity Analysis
6. GLOBAL VETERINARY COMPOUNDING PHARMACIES MARKET FORECAST, BY FORMULATION, 2012 - 2016 AND FORECAST, 2017 – 2023
6.1. Flavoured Liquids
6.1.1. Market Analysis, 2012 - 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
6.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.1.3. Market Opportunity Analysis
6.2. Tablet Triturates
6.2.1. Market Analysis, 2012 - 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
6.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.2.3. Market Opportunity Analysis
6.3. Transdermal
6.3.1. Market Analysis, 2012 - 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
6.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.3.3. Market Opportunity Analysis
6.4. Capsules
6.4.1. Market Analysis, 2012 - 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
6.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.4.3. Market Opportunity Analysis
6.5. Flavoured pastes
6.5.1. Market Analysis, 2012 - 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
6.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.5.3. Market Opportunity Analysis
7. GLOBAL VETERINARY COMPOUNDING PHARMACIES MARKET FORECAST, BY REGION, 2012 - 2016 AND FORECAST, 2017 – 2023 (REVENUE, USD MN)
7.1. North America
7.1.1. Market Analysis, 2012 - 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
7.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.1.3. Market Opportunity Analysis
7.2. Europe
7.2.1. Market Analysis, 2012 - 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
7.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.2.3. Market Opportunity Analysis
7.3. Asia-Pacific
7.3.1. Market Analysis, 2012 - 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
7.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.3.3. Market Opportunity Analysis
7.4. Latin America
7.4.1. Market Analysis, 2012 - 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
7.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.4.3. Market Opportunity Analysis
7.5. Middle East and Africa
7.5.1. Market Analysis, 2012 - 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
7.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.5.3. Market Opportunity Analysis
7.6. Global Veterinary Compounding Pharmacies Market - Opportunity Analysis Index, By Animal Type, By Formulation and Region, 2017 – 2023
8. NORTH AMERICA VETERINARY COMPOUNDING PHARMACIES MARKET ANALYSIS, 2012 - 2016 AND FORECAST, 2017 – 2023 (REVENUE, USD MN)
8.1. Animal Type Analysis, 2012 - 2016 and Forecast 2017 – 2023 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
8.1.1. Swine
8.1.2. Bovine
8.1.3. Equine
8.1.4. Canine
8.2. Formulation Analysis, 2012- 2016 and Forecast 2017 – 2023 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
8.2.1. Veterinary Clinics
8.2.2. Veterinary pharmacies
8.2.3. Online pharmacies
8.2.4. Others
8.3. Country Analysis 2016 and Forecast 2017 – 2023 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
8.3.1. U.S.
8.3.2. Canada
8.4. North America Veterinary Compounding Pharmacies Market - Opportunity Analysis Index, By Animal Type, By Formulation and Country, 2017 – 2023
8.5. North America Veterinary Compounding Pharmacies Market Dynamics – Trends
9. EUROPE VETERINARY COMPOUNDING PHARMACIES MARKET ANALYSIS, 2012 - 2016 AND FORECAST, 2017 – 2023 (REVENUE, USD MN)
9.1. Animal Type Analysis, 2012 - 2016 and Forecast 2017 – 2023 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
9.1.1. Swine
9.1.2. Bovine
9.1.3. Equine
9.1.4. Canine
9.2. Formulation Analysis, 2012- 2016 and Forecast 2017 – 2023 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
9.2.1. Veterinary Clinics
9.2.2. Veterinary pharmacies
9.2.3. Online pharmacies
9.2.4. Others
9.3. Country Analysis 2012 - 2016 and Forecast 2017 – 2023 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
9.3.1. Germany
9.3.2. UK
9.3.3. France
9.3.4. Spain
9.3.5. Italy
9.3.6. Russia
9.3.7. Poland
9.3.8. Rest of Europe
9.4. Europe Veterinary Compounding Pharmacies Market - Opportunity Analysis Index, By Animal Type, By Formulation and Country, 2017 – 2023
9.5. Europe Veterinary Compounding Pharmacies Market Dynamics – Trends
10. ASIA-PACIFIC VETERINARY COMPOUNDING PHARMACIES MARKET ANALYSIS, 2012 - 2016 AND FORECAST, 2017 – 2023 (REVENUE, USD MN)
10.1. Animal Type Analysis, 2012 - 2016 and Forecast 2017 – 2023 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
10.1.1. Swine
10.1.2. Bovine
10.1.3. Equine
10.1.4. Canine
10.2. Formulation Analysis, 2012- 2016 and Forecast 2017 – 2023 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
10.2.1. Veterinary Clinics
10.2.2. Veterinary pharmacies
10.2.3. Online pharmacies
10.2.4. Others
10.3. Country Analysis 2012 - 2016 and Forecast 2017 – 2023 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
10.3.1. Japan
10.3.2. China
10.3.3. India
10.3.4. ASEAN
10.3.5. Australia & New Zealand
10.3.6. Rest of Asia-Pacific
10.4. Asia-Pacific Veterinary Compounding Pharmacies Market - Opportunity Analysis Index, By Animal Type, By Formulation and Country, 2017 – 2023
10.5. Asia-Pacific Veterinary Compounding Pharmacies Market Dynamics – Trends
11. LATIN AMERICA VETERINARY COMPOUNDING PHARMACIES MARKET ANALYSIS, 2012 - 2012 - 2012 - 2016 AND FORECAST, 2017 – 2023 (REVENUE, USD MN)
11.1. Animal Type Analysis, 2012 - 2016 and Forecast 2017 – 2023 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
11.1.1. Swine
11.1.2. Bovine
11.1.3. Equine
11.1.4. Canine
11.2. Formulation Analysis, 2012- 2016 and Forecast 2017 – 2023 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
11.2.1. Veterinary Clinics
11.2.2. Veterinary pharmacies
11.2.3. Online pharmacies
11.2.4. Others
11.3. Country Analysis 2012 - 2016 and Forecast 2017 – 2023 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
11.3.1. Brazil
11.3.2. Mexico
11.3.3. Argentina
11.3.4. Venezuela
11.3.5. Rest of Latin America
11.4. Latin America Veterinary Compounding Pharmacies Market - Opportunity Analysis Index, By Animal Type, By Formulation and Country, 2017 – 2023
11.5. Latin America Veterinary Compounding Pharmacies Market Dynamics – Trends
12. MIDDLE EAST AND AFRICA VETERINARY COMPOUNDING PHARMACIES MARKET ANALYSIS, 2012 - 2016 AND FORECAST, 2017 – 2023 (REVENUE, USD MN)
12.1. Animal Type Analysis, 2012 - 2016 and Forecast 2017 – 2023 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
12.1.1. Swine
12.1.2. Bovine
12.1.3. Equine
12.1.4. Canine
12.2. Formulation Analysis, 2012- 2016 and Forecast 2017 – 2023 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
12.2.1. Veterinary Clinics
12.2.2. Veterinary pharmacies
12.2.3. Online pharmacies
12.2.4. Others
12.3. Country Analysis 2012 - 2016 and Forecast 2017 – 2023 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
12.3.1. Gulf Cooperation Council (GCC) Countries
12.3.2. Israel
12.3.3. South Africa
12.3.4. Rest of MEA
12.4. MEA Veterinary Compounding Pharmacies Market - Opportunity Analysis Index, By Animal Type, By Formulation and Country, 2017 – 2023
12.5. MEA Veterinary Compounding Pharmacies Market Dynamics – Trends
13. COMPETITION LANDSCAPE
13.1. Strategic Dashboard of Top Market Players
13.2. Company Profiles (Introduction, Financial Analysis, Product & Service Offerings, Key Developments, Strategies, and SWOT Analysis)
13.2.1. Triangle Compounding Pharmacy Inc. (U.S)
13.2.2. Diamondback Drugs LLC (U.S)
13.2.3. Lorraine’s Pharmacy (Ontario)
13.2.4. Medisca Inc. (Canada)
13.2.5. Slade Dispensary Services (Australia)
13.2.6. Wedgewood Pharmacy (U.S)
13.2.7. Essential Pharmacy Compounding Vet (Kohll’s Pharmacy & Homecare) (U.S)
14. RESEARCH METHODOLOGY
15. KEY ASSUMPTIONS AND ACRONYMS
